Monocyte Chemoattractant Protein-1 Expression in Aortic Tissues of Hypertensive Rats

Hypertension ◽  
1997 ◽  
Vol 30 (6) ◽  
pp. 1397-1402 ◽  
Author(s):  
Quinn Capers ◽  
R. Wayne Alexander ◽  
Pingping Lou ◽  
Hector De Leon ◽  
Josiah N. Wilcox ◽  
...  
Keyword(s):  
Hypertensive Rats ◽  
Monocyte Chemoattractant Protein 1 ◽  
Monocyte Chemoattractant ◽  
Monocyte Chemoattractant Protein

scholarly journals Anti—Monocyte Chemoattractant Protein-1 Gene Therapy Protects against Focal Brain Ischemia in Hypertensive Rats

2004 ◽  
Vol 24 (12) ◽  
pp. 1359-1368 ◽  
Author(s):  
Yasuhiro Kumai ◽  
Hiroaki Ooboshi ◽  
Junichi Takada ◽  
Masahiro Kamouchi ◽  
Takanari Kitazono ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Gene Transfer ◽  
Brain Ischemia ◽  
Infarct Volume ◽  
Dominant Negative ◽  
Hypertensive Rats ◽  
Monocyte Chemoattractant Protein 1 ◽  
Monocyte Chemoattractant ◽  
Monocyte Chemoattractant Protein ◽  
Focal Brain Ischemia

Monocyte chemoattractant protein-1 (MCP-1) is expressed in the ischemic cortex after focal brain ischemia and appears to exacerbate ischemic damage. The authors examined the effect of gene transfer of dominant negative MCP-1, called 7ND, 90 minutes after induction of focal brain ischemia in hypertensive rats. Adenoviral vectors encoding mutant MCP-1 (Ad7ND; n = 11), or Escherichia coli β-galactosidase (AdlacZ; n = 17) as control were injected into the lateral ventricle of male spontaneously hypertensive rats. Both AdlacZ (n = 12) and Ad7ND (n = 6) administration provided transgene expression as early as 6 hours after injection and the expression further increased on day 1, followed by a sustained detection on day 5. Five days after ischemia, infarct volume (75 ± 13 mm3, n = 5, mean ± SD) significantly reduced to 72% of control (104 ± 22 mm3, n = 5, P < 0.05) by 7ND gene transfer. Numbers of leukocytes in the vessels (48.3 ± 32.9/cm2) and macrophage/monocyte infiltration (475.2 ± 125.5 /mm2) of the infarct area in the Ad7ND group were significantly less than those measured in the AdlacZ group (143.8 ± 72.1/cm2 and 671.8 ± 125.5/mm2, P < 0.05, respectively). In summary, the postischemic gene transfer of dominant negative MCP-1 attenuated the infarct volume and infiltration of inflammatory cells, suggesting potential usefulness of the anti–MCP-1 gene therapy.

Sign in / Sign up

Export Citation Format

Share Document